Abstract
Objective: Endogenous activation of matrix metalloproteinase (MMP) in human fetal membranes is hypothesized to contribute to membrane weakening leading to early rupture and is also involved in the initiation of labor. Our laboratory and several others have studied the source and action of some of these MMPs. The objective of this study is to document the expression pattern of most of the MMPs cloned and sequenced so far in amniochorion during preterm premature rupture of membranes (pPROM), at term not in labor and during term labor.
Materials and Methods: Placentas were collected from women with PROM, term not in labor after C-sections and from women after term vaginal delivery. Membranes were separated from the placenta and a section away from the rupture site was selected. Amniochorion were separated from the placenta. RT-PCR was performed to study the expression pattern of MMP15 (MT2-MMP), MMP16 (MT3-MMP), MMP17 (MT4-MMP), MMP18, MMP20, MMP23, MMP24 (MT5-MMP), MMP25 (MT6-MMP), and MMP 26 using specific primers.
Results: A differential pattern of expression was noted for some of the novel MMPs screened in this study in human fetal membranes. mRNA for most of the MMPs were expressed by amniochorion. MMP16 [membrane type metalloproteinase 3], MMP20 [enamelysin], and MMP26 [matrilysin] were not expressed.
Conclusion: Amniochorion expresses several of the MMP genes at the time of pPROM, term not in labor and during active labor. We have previously reported the expression pattern of other MMPs and their inhibitors and their potential role in PROM. These findings support our hypothesis that amniochorion has a fully functional MMP system.
Keywords: Amniochorion, MMP, MT-MMP, PCR, premature rupture of the membranes, preterm labor
Full Text
The Full Text of this article is available as a PDF (51.2 KB).
REFERENCES
- 1.French JI, McGregor JA. The pathobiology of premature rupture of membranes. Semin Perinatol. 1996;20:344–368. doi: 10.1016/s0146-0005(96)80002-4. [DOI] [PubMed] [Google Scholar]
- 2.Fortunato SJ, Menon R, Lombardi SJ. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane. Am J Obstet Gynecol. 1997;177:731–741. doi: 10.1016/s0002-9378(97)70260-6. [DOI] [PubMed] [Google Scholar]
- 3.Fortunato SJ, Menon R, Lombardi SJ. Amniochorion gelatinase-gelatinase inhibitor imbalance in vitro: A possible infectious pathway to rupture. Obstet Gynecol. 2000;95:240–244. doi: 10.1016/s0029-7844(99)00503-7. [DOI] [PubMed] [Google Scholar]
- 4.Fortunato SJ, Menon R, Lombardi SJ. MMP/TIMP imbalance in amniotic fluid during PROM: An indirect support for endogenous pathway to membrane rupture. J Perinat Med. 1999;27:362–368. doi: 10.1515/JPM.1999.049. [DOI] [PubMed] [Google Scholar]
- 5.Woessner J., Jr Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145–2154. [PubMed] [Google Scholar]
- 6.Murphy G, Docherty AJ, Hembry RM, Reynolds JJ. Metalloproteinases and tissue damage. Br J Rheumatol. 1991;30(Suppl1):25–31. [PubMed] [Google Scholar]
- 7.Fortunato SJ, Menon R, Lombardi SJ. Expression of a progelatinase activator (MT1-MMP) in human fetal membranes. Am J Reprod Immunol. 1998;39:316–322. doi: 10.1111/j.1600-0897.1998.tb00524.x. [DOI] [PubMed] [Google Scholar]
- 8.Fortunato SJ, Menon R, Lombardi SJ. Stromelysins in placental membranes and amniotic fluid with premature rupture of membranes. Obstet Gynecol. 1999;94:435–440. doi: 10.1016/s0029-7844(99)00336-1. [DOI] [PubMed] [Google Scholar]
- 9.Fortunato SJ, Menon R, Lombardi SJ. Presence of four tissue inhibitors of matrix metalloproteinases (TIMP 1, 2, 3 and 4) in human fetal membranes. Am J Reprod Immunol. 1998;40:395–400. doi: 10.1111/j.1600-0897.1998.tb00424.x. [DOI] [PubMed] [Google Scholar]
- 10.Fortunato SJ, Menon R, Lombardi SJ, LaFluer B: Collagenase-3 (Matrix Metalloproteinase-13) in fetal membranes and amniotic fluid during pregnancy. Am J Reprod Immunol in press. [DOI] [PubMed]
- 11.Giambernardi TA, Grant GM, Taylor GP, Hay RJ, Maher VM, McCormick JJ, Klebe RJ. Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol. 1998;16:483–496. doi: 10.1016/s0945-053x(98)90019-1. [DOI] [PubMed] [Google Scholar]
- 12.Grant GM, Giambernardi TA, Grant AM, Klebe RJ. Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells. Matrix Biol. 1999;18:145–148. doi: 10.1016/s0945-053x(99)00003-7. [DOI] [PubMed] [Google Scholar]
- 13.Murphy G, Knauper V, Cowell S, Hembry R, Stanton H, Butler G, Freije J, Pendas AM, Lopez-Otin C. Evaluation of some newer matrix metalloproteinases. Ann N Y Acad Sci. 1999;878:25–39. doi: 10.1111/j.1749-6632.1999.tb07672.x. [DOI] [PubMed] [Google Scholar]
- 14.Skinner SJ, Campos GA, Liggins GC. Collagen content of human amniotic membranes: Effect of gestation length and premature rupture. Obstet Gynecol. 1981;57:487–489. [PubMed] [Google Scholar]
- 15.Malak TM, Ockleford CD, Bell SC, Dalgleish R, Bright N, Macvicar J. Confocal immunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastructural organization in term human fetal membranes. Placenta. 1993;14:385–406. doi: 10.1016/s0143-4004(05)80460-6. [DOI] [PubMed] [Google Scholar]
- 16.Draper D, McGregor J, Hall J, Jones W, Beutz M, Heine RP, Porreco R. Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes. Am J Obstet Gynecol. 1995;173:1506–1512. doi: 10.1016/0002-9378(95)90640-1. [DOI] [PubMed] [Google Scholar]
- 17.Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, Bermejo L. I., Strauss JF., III Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol. 1996;174:1371–1376. doi: 10.1016/s0002-9378(96)70687-7. [DOI] [PubMed] [Google Scholar]
- 18.McLaren J, Taylor DJ, Bell SC. Increased concentration of promatrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: Implications for membrane remodeling and rupture. Am J Obstet Gynecol. 2000;182:409–416. doi: 10.1016/s0002-9378(00)70232-8. [DOI] [PubMed] [Google Scholar]
- 19.Athayde N, Edwin SS, Romero R, Draper D, McGregor J, Hall J, Jones W, Beutz M, Heine RP, Porreco R. A role for MMP-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol. 1998;179:1248–1253. doi: 10.1016/s0002-9378(98)70141-3. [DOI] [PubMed] [Google Scholar]
- 20.Maymon E, Romero R, Pacora P, Gervasi MT, Bianco K, Ghezzi F, Draper D, McGregor J, Hall J, Jones W, Beutz M, Heine RP, Porreco R. Evidence for the participation of interstitial collagenase (MMP 1) in preterm premature rupture of membranes. Am J Obstet Gynecol. 2000;183:914–920. doi: 10.1067/mob.2000.108879. [DOI] [PubMed] [Google Scholar]
- 21.Fortunato SJ, Menon R, Lombardi SJ. Expression of a progelatinase activator (MT1-MMP) in human fetal membranes. Am J Reprod Immunol. 1998;39:316–322. doi: 10.1111/j.1600-0897.1998.tb00524.x. [DOI] [PubMed] [Google Scholar]